A new study from leading U.S. think tank National Bureau of Economic Research has shown (once again) that lockdown policies produced no discernible reduction of the pandemic death toll. If anything, they increased it.
A new study in the journal Vaccines concludes that for every three deaths the vaccines prevent, one person dies from an adverse reaction while another four suffer serious side effects. Time to reconsider, they ask?
Imperial's REACT study reconstructs the epidemic curve in England from the symptom onset dates of people with antibodies. It shows that infections always declined before lockdown and sometimes increased under it.
The Principle trial at Oxford University has selected Ivermectin for inclusion in its study of repurposed drugs for COVID-19, meaning 14 months after its potential was discovered the drug might finally be approved.
The models from SAGE and others all forecast a huge summer surge as we reopen, but the predictions are already wrong. With the peak expected in the next month, we'll soon know how wrong they are.
The sixth of our weekly round-ups of Covid vaccine safety reports and news from a group of medical doctors to inform the debate on vaccination.
The Prime Minister has said there may be a "rough winter" ahead. But since by the Government's own admission lockdowns appear to be the cause of the pressures on the NHS, the cycle of lockdowns will never end.
New research in the Journal of Infection looks at the PCR test results from a large lab in Munster and finds that more than half do not indicate infectious virus, casting doubt on the test's "gold standard" status.
Lockdown Sceptics received a fantastic response to our call for news from the reopened states in America with which to shame our own timid Government as it delayed reopening for yet another month. Here they are.
GP Dr Helen Westwood has written to her MP Graham Brady expressing her concerns about the possible plans for mandatory vaccination of healthcare workers and calling for Matt Hancock to be sacked.
© 2026 Skeptics Ltd.
